Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMRN Immuron Ltd

盘后交易 10-31 19:06:06 EDT

1.92

+0.00

0.00%

最高1.94	最低1.92	成交量1,103
今开1.92	昨收1.92	日振幅0.98%
总市值1,100万	流通市值941.37万	总股本572.86万
成交额2,123	换手率0.02%	流通股本490.29万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMRN","market":"US","secType":"STK","nameCN":"Immuron Ltd","latestPrice":1.92,"timestamp":1730404800000,"preClose":1.92,"halted":0,"volume":1103,"delay":0,"floatShares":4902946,"shares":5728635,"eps":-0.812463,"marketStatus":"盘后交易","marketStatusCode":4,"change":0,"latestTime":"10-31 19:06:06 EDT","open":1.92,"high":1.9388,"low":1.92,"amount":2122.938695,"amplitude":0.009792,"askPrice":2.77,"askSize":100,"bidPrice":1.74,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.812463,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1730419200000},"adr":1,"adjPreClose":1.92,"adrRate":40,"volumeRatio":0.191513},"requestUrl":"/m/hq/s/IMRN/tweets","defaultTab":"tweets","newsList":[{"id":"2477919866","title":"Immuron Limited盘中异动 早盘股价大涨6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477919866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477919866?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:52","pubTimestamp":1729518775,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时52分，Immuron Limited股票出现波动，股价急速上涨6.49%。截至发稿，该股报2.03美元/股，成交量115股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.53%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121525598e3d890&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121525598e3d890&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2475906919","title":"Immuron Limited盘中异动 早盘股价大涨6.95%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475906919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475906919?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:32","pubTimestamp":1729085555,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时32分，Immuron Limited股票出现波动，股价快速拉升6.95%。截至发稿，该股报2.00美元/股，成交量2035股，换手率0.04%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.28%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101621323595ad0c54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101621323595ad0c54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2475638241","title":"Immuron Limited盘中异动 早盘大幅下跌5.85%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475638241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475638241?lang=zh_cn&edition=full","pubTime":"2024-10-15 22:59","pubTimestamp":1729004397,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日22时59分，Immuron Limited股票出现异动，股价急速下跌5.85%。截至发稿，该股报2.09美元/股，成交量2087股，换手率0.04%，振幅1.35%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.58%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015225957a1e0d9e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015225957a1e0d9e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2475367659","title":"Immuron Limited盘中异动 早盘股价大跌8.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475367659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475367659?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:31","pubTimestamp":1728912712,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日21时31分，Immuron Limited股票出现波动，股价快速下跌8.18%。截至发稿，该股报2.02美元/股，成交量813股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.08%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410142131529f41ca7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410142131529f41ca7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2474946090","title":"Immuron Limited盘中异动 早盘快速拉升9.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474946090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474946090?lang=zh_cn&edition=full","pubTime":"2024-10-11 21:32","pubTimestamp":1728653520,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日21时32分，Immuron Limited股票出现波动，股价大幅上涨9.87%。截至发稿，该股报2.45美元/股，成交量288股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.59%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112132009f3aa4bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112132009f3aa4bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2474372533","title":"Immuron Limited股价飙升13.80% 市值涨197.66万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474372533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474372533?lang=zh_cn&edition=full","pubTime":"2024-10-10 23:42","pubTimestamp":1728574943,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日23时42分，Immuron Limited股票出现异动，股价大幅上涨13.80%。截至发稿，该股报2.52美元/股，成交量168股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.37%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102342249719f8d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102342249719f8d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2474054954","title":"Immuron Limited盘中异动 下午盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474054954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474054954?lang=zh_cn&edition=full","pubTime":"2024-10-09 01:08","pubTimestamp":1728407300,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日01时08分，Immuron Limited股票出现波动，股价急速上涨5.10%。截至发稿，该股报2.44美元/股，成交量1236股，换手率0.02%，振幅6.68%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.03%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090108209719f049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090108209719f049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2473058091","title":"Immuron Limited盘中异动 大幅下跌5.95%报2.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473058091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473058091?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:33","pubTimestamp":1728308000,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时33分，Immuron Limited股票出现异动，股价急速跳水5.95%。截至发稿，该股报2.53美元/股，成交量236股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.16%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213320ab681a7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213320ab681a7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2472796349","title":"Immuron Limited盘中异动 股价大跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472796349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472796349?lang=zh_cn&edition=full","pubTime":"2024-10-04 22:33","pubTimestamp":1728052400,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日22时33分，Immuron Limited股票出现异动，股价大幅下挫5.40%。截至发稿，该股报2.59美元/股，成交量3360股，换手率0.06%，振幅2.92%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.25%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004223320ab67be5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004223320ab67be5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2470273475","title":"Immuron Limited盘中异动 早盘快速下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470273475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470273475?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:32","pubTimestamp":1727357555,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时32分，Immuron Limited股票出现波动，股价快速下跌5.17%。截至发稿，该股报2.66美元/股，成交量2760股，换手率0.05%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.39%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213235957f799b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213235957f799b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","KTTA","BK4139"],"gpt_icon":0},{"id":"2469494942","title":"Immuron Limited盘中异动 股价大涨12.73%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469494942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469494942?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:31","pubTimestamp":1727184683,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时31分，Immuron Limited股票出现异动，股价大幅拉升12.73%。截至发稿，该股报2.79美元/股，成交量2000股，换手率0.04%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.34%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242131239f132330&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242131239f132330&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2469485261","title":"Immuron Limited盘中异动 早盘股价大涨6.18%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469485261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469485261?lang=zh_cn&edition=full","pubTime":"2024-09-23 22:22","pubTimestamp":1727101378,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日22时22分，Immuron Limited股票出现波动，股价快速上涨6.18%。截至发稿，该股报2.67美元/股，成交量792股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.55%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923222258a1dbeed5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923222258a1dbeed5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2460888588","title":"Immuron Limited盘中异动 股价大涨5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460888588","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460888588?lang=zh_cn&edition=full","pubTime":"2024-08-20 23:18","pubTimestamp":1724167138,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日23时18分，Immuron Limited股票出现异动，股价急速拉升5.64%。截至发稿，该股报2.62美元/股，成交量340股，换手率0.01%，振幅0.32%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.30%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082023185897199568&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082023185897199568&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2459348313","title":"Immuron Limited盘中异动 下午盘快速跳水5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459348313","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459348313?lang=zh_cn&edition=full","pubTime":"2024-08-15 01:46","pubTimestamp":1723657601,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日01时46分，Immuron Limited股票出现波动，股价急速下跌5.30%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.50%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815014641aefec1a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815014641aefec1a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2457216024","title":"Immuron Limited盘中异动 急速上涨7.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457216024","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457216024?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:54","pubTimestamp":1722956067,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日22时54分，Immuron Limited股票出现异动，股价快速拉升7.23%。Immuron Limited股票所在的生物技术行业中，整体涨幅为2.19%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806225427aefd8808&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806225427aefd8808&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2457775522","title":"Immuron Limited盘中异动 早盘大幅跳水6.25%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775522","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775522?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:43","pubTimestamp":1722865417,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时43分，Immuron Limited股票出现异动，股价快速跳水6.25%。截至发稿，该股报2.36美元/股，成交量924股，换手率0.02%，振幅1.98%。Immuron Limited股票所在的生物技术行业中，整体跌幅为1.93%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214337971988cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214337971988cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2456287657","title":"Immuron Limited盘中异动 早盘股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456287657","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456287657?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:00","pubTimestamp":1722607208,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日22时00分，Immuron Limited股票出现异动，股价大幅拉升5.32%。截至发稿，该股报2.63美元/股，成交量2914股，换手率0.05%，振幅4.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为1.08%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802220008af95a787&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802220008af95a787&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2455937970","title":"Immuron Limited盘中异动 急速上涨7.53%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455937970","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455937970?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:31","pubTimestamp":1722346302,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日21时31分，Immuron Limited股票出现异动，股价大幅拉升7.53%。截至发稿，该股报2.57美元/股，成交量131股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.66%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730213142af94db96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730213142af94db96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2454374598","title":"Immuron Limited盘中异动 快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454374598","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454374598?lang=zh_cn&edition=full","pubTime":"2024-07-27 02:52","pubTimestamp":1722019933,"startTime":"0","endTime":"0","summary":"北京时间2024年07月27日02时52分，Immuron Limited股票出现波动，股价急速拉升5.03%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.17%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072702521496820dbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072702521496820dbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2454887138","title":"Immuron Limited盘中异动 急速下跌20.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454887138","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454887138?lang=zh_cn&edition=full","pubTime":"2024-07-25 21:40","pubTimestamp":1721914838,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日21时40分，Immuron Limited股票出现波动，股价快速下挫20.78%。截至发稿，该股报2.02美元/股，成交量76股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.37%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725214038aefb76b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725214038aefb76b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immuron.com","stockEarnings":[{"period":"1week","weight":-0.0154},{"period":"1month","weight":-0.2941},{"period":"3month","weight":-0.232},{"period":"6month","weight":-0.2381},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.024}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0109},{"period":"3month","weight":0.0681},{"period":"6month","weight":0.1344},{"period":"1year","weight":0.3869},{"period":"ytd","weight":0.2203}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immuron Limited于1994年根据澳大利亚法律成立。该公司是一家商业和临床阶段的生物制药公司，拥有一个专利技术平台，专注于开发和商业化一类新型的特异性靶向多克隆抗体，公司相信这种抗体能够解决严重的未满足医疗需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.236802},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.076928},{"month":3,"riseRate":0.428571,"avgChangeRate":0.034557},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.002953},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.10596},{"month":6,"riseRate":0.5,"avgChangeRate":0.38465},{"month":7,"riseRate":0.571429,"avgChangeRate":0.032443},{"month":8,"riseRate":0.571429,"avgChangeRate":-0.018746},{"month":9,"riseRate":0.375,"avgChangeRate":-0.070912},{"month":10,"riseRate":0.125,"avgChangeRate":-0.095831},{"month":11,"riseRate":0.571429,"avgChangeRate":0.04362},{"month":12,"riseRate":0.142857,"avgChangeRate":-0.090493}],"exchange":"NASDAQ","name":"Immuron Ltd","nameEN":"Immuron Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immuron Ltd,IMRN,Immuron Ltd股票,Immuron Ltd股票老虎,Immuron Ltd股票老虎国际,Immuron Ltd行情,Immuron Ltd股票行情,Immuron Ltd股价,Immuron Ltd股市,Immuron Ltd股票价格,Immuron Ltd股票交易,Immuron Ltd股票购买,Immuron Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}